Tasquinimod Clinical Trials
2 recruitingDrug
Phase 12Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)
Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-Essential Thrombocytosis Myelofibrosis
M.D. Anderson Cancer Center33 enrolled1 locationNCT06327100
Recruiting
Phase 1Phase 2
Tasquinimod in Patients with Myelofibrosis Refractory to or Intolerant for JAK2 Inhibition
Myelofibrosis
Stichting Hemato-Oncologie voor Volwassenen Nederland20 enrolled6 locationsNCT06605586